Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Topoisomerase II alpha anticorps (AA 1352-1493)

Cet anticorps Souris Monoclonal détecte spécifiquement Topoisomerase II alpha dans WB, IHC et IF. Il présente une réactivité avec des échantillons de Humain et Souris.
N° du produit ABIN6940773
639,45 €
Plus frais de livraison 40,00 € et TVA
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour Topoisomerase II alpha anticorps (AA 1352-1493) (ABIN6940773)

Antigène

Voir toutes Topoisomerase II alpha (TOP2A) Anticorps
Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

Reactivité

  • 173
  • 79
  • 45
  • 7
  • 6
  • 3
  • 3
  • 3
  • 1
Humain, Souris

Hôte

  • 129
  • 45
Souris

Clonalité

  • 97
  • 77
Monoclonal

Conjugué

  • 101
  • 10
  • 6
  • 6
  • 6
  • 6
  • 6
  • 6
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Topoisomerase II alpha est non-conjugé

Application

  • 124
  • 90
  • 52
  • 49
  • 23
  • 23
  • 21
  • 8
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), Immunofluorescence (IF)

Clone

TOP2A-1361
  • Épitope

    • 21
    • 15
    • 11
    • 10
    • 8
    • 8
    • 8
    • 7
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1352-1493

    Fonction

    Topoisomerase II alpha (Proliferation & Drug-Resistance Marker) Antibody

    Specificité

    It recognizes a 170 kDa protein, which is identified as topoisomerase II is also implicated in drug resistance of tumor cells and has been shown to be over-expressed in many human cancers. Decreased expression of Topo IIa is the predominant mechanism of resistance to several chemotherapeutic agents.

    Purification

    200ug/ml of Ab Purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant human Topoisomerase II alpha fragment (aa1352-1493)

    Isotype

    IgG2b, kappa
  • Indications d'application

    Positive Control: HeLa cells. Tonsil.

    Known Application: Immunofluorescence (1-2 μg/mL), Western Blot (0.5-1 μg/mL), Immunohistochemistry (Formalin-fixed) (0.5-1 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate Buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes)Optimal dilution for a specific application should be determined.

    Restrictions

    For Research Use only
  • Concentration

    200 μg/mL

    Buffer

    Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

    Autre désignation

    TOP2A

    Sujet

    ATP hydrolyzing DNA topoisomerase II alfa, DNA gyrase, DNA topoisomerase (ATP hydrolyzing), DNA topoisomerase 2 alpha, DNA topoisomerase II 170kD, DNA topoisomerase II alpha, DNA Topoisomerase2, TOP2A, Topoisomerase DNA II alpha 170 kDa, TP2A

    HeLa cells. Tonsil.

    Poids moléculaire

    170kDa

    ID gène

    7153, 156346

    UniProt

    P11388

    Pathways

    Cycle Cellulaire, Mitotic G1-G1/S Phases
Vous êtes ici:
Chat with us!